Trial intelligence / Profile preview

Pregabalin for Catheter-Related Bladder Discomfort in Urological Operations

NCT03229668Phase 3Completed

Sponsor
Saint Savvas Anticancer Hospital
Start
Jul 2017
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of pregabalin in cystitis (3 arms), sponsored by Saint Savvas Anticancer Hospital. Primary endpoint: Percentage of postsurgical catheter-related bladder discomfort at 24 hours. Started Jul 2017; status: completed.

02

Drugs

pregabalin
03

Conditions

cystitis

Beyond the preview

Go deeper on NCT03229668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03229668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call